Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
The Krainer lab discovered a three-oncogene circuit that helps drive the aggressive progression of pancreatic ductal ...
BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated with glufosfamide. The study revealed four patient clusters, with one ...
Doctors may soon have a new tool in the fight against one of the most aggressive and lethal forms of cancer—in the form of an 'early warning' signature of precancerous cells. This is the promise of a ...